These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 36639017)

  • 41. Dehydroandrographolide ameliorates doxorubicin-mediated cardiotoxicity by regulating autophagy through the mTOR-TFEB pathway.
    Duan Y; Huang P; Sun L; Wang P; Cai Y; Shi T; Li Y; Zhou Y; Yu S
    Chem Biol Interact; 2024 Aug; 399():111132. PubMed ID: 38964637
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adiponectin agonist ADP355 ameliorates doxorubicin-induced cardiotoxicity by decreasing cardiomyocyte apoptosis and oxidative stress.
    Zhao D; Xue C; Li J; Feng K; Zeng P; Chen Y; Duan Y; Zhang S; Li X; Han J; Yang X
    Biochem Biophys Res Commun; 2020 Dec; 533(3):304-312. PubMed ID: 32958254
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Spinacetin alleviates doxorubicin-induced cardiotoxicity by initiating protective autophagy through SIRT3/AMPK/mTOR pathways.
    Liu D; Zhao L
    Phytomedicine; 2022 Jul; 101():154098. PubMed ID: 35430482
    [TBL] [Abstract][Full Text] [Related]  

  • 44. LCZ696 protects against doxorubicin-induced cardiotoxicity by inhibiting ferroptosis via AKT/SIRT3/SOD2 signaling pathway activation.
    Liu X; Li D; Pi W; Wang B; Xu S; Yu L; Yao L; Sun Z; Jiang J; Mi Y
    Int Immunopharmacol; 2022 Dec; 113(Pt A):109379. PubMed ID: 36330913
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Irisin protects against doxorubicin-induced cardiotoxicity by improving AMPK-Nrf2 dependent mitochondrial fusion and strengthening endogenous anti-oxidant defense mechanisms.
    Zhuo C; Xin J; Huang W; Zhang D; Yan X; Li R; Li H; Lan J; Lin L; Li L; Wang X; Liu L; Wang Y; Li X; Mao Y; Chen H; Wu S; Yang X; Jiang W
    Toxicology; 2023 Aug; 494():153597. PubMed ID: 37499777
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Low concentration of rutin treatment might alleviate the cardiotoxicity effect of pirarubicin on cardiomyocytes via activation of PI3K/AKT/mTOR signaling pathway.
    Fei J; Sun Y; Duan Y; Xia J; Yu S; Ouyang P; Wang T; Zhang G
    Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31138757
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Astragaloside IV inhibits doxorubicin-induced cardiomyocyte apoptosis mediated by mitochondrial apoptotic pathway via activating the PI3K/Akt pathway.
    Jia Y; Zuo D; Li Z; Liu H; Dai Z; Cai J; Pang L; Wu Y
    Chem Pharm Bull (Tokyo); 2014; 62(1):45-53. PubMed ID: 24390491
    [TBL] [Abstract][Full Text] [Related]  

  • 48. PAE ameliorates doxorubicin-induced cardiotoxicity via suppressing NHE1 phosphorylation and stimulating PI3K/AKT phosphorylation.
    Yin Y; Niu Q; Hou H; Que H; Mi S; Yang J; Li Z; Wang H; Yu Y; Zhu M; Zhan H; Wang Q; Li P
    Int Immunopharmacol; 2022 Dec; 113(Pt A):109274. PubMed ID: 36252472
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MicroRNA-495-3p diminishes doxorubicin-induced cardiotoxicity through activating AKT.
    Meng J; Xu C
    J Cell Mol Med; 2022 Apr; 26(7):2076-2088. PubMed ID: 35152537
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Erythropoietin protects against doxorubicin-induced cardiomyopathy via a phosphatidylinositol 3-kinase-dependent pathway.
    Kim KH; Oudit GY; Backx PH
    J Pharmacol Exp Ther; 2008 Jan; 324(1):160-9. PubMed ID: 17928571
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Aucubin alleviates doxorubicin-induced cardiotoxicity through crosstalk between NRF2 and HIPK2 mediating autophagy and apoptosis.
    Li W; Cao J; Zhang Y; Ling G; Tan N; Wei Y; Zhang Y; Wang X; Qian W; Jiang J; Zhang J; Wang W; Wang Y
    Phytomedicine; 2024 May; 127():155473. PubMed ID: 38422972
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Time course of changes in oxidative stress and stress-induced proteins in cardiomyocytes exposed to doxorubicin and prevention by vitamin C.
    Ludke A; Akolkar G; Ayyappan P; Sharma AK; Singal PK
    PLoS One; 2017; 12(7):e0179452. PubMed ID: 28678856
    [TBL] [Abstract][Full Text] [Related]  

  • 53. C1qTNF-related protein-6 protects against doxorubicin-induced cardiac injury.
    Zheng WF; Zhang SY; Ma HF; Chang XW; Wang H
    J Cell Biochem; 2019 Jun; 120(6):10748-10755. PubMed ID: 30719766
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Aldehyde dehydrogenase 2 ameliorates doxorubicin-induced myocardial dysfunction through detoxification of 4-HNE and suppression of autophagy.
    Sun A; Cheng Y; Zhang Y; Zhang Q; Wang S; Tian S; Zou Y; Hu K; Ren J; Ge J
    J Mol Cell Cardiol; 2014 Jun; 71():92-104. PubMed ID: 24434637
    [TBL] [Abstract][Full Text] [Related]  

  • 55. SIRT3 attenuates doxorubicin-induced cardiotoxicity by inhibiting NLRP3 inflammasome via autophagy.
    Sun Z; Fang C; Xu S; Wang B; Li D; Liu X; Mi Y; Guo H; Jiang J
    Biochem Pharmacol; 2023 Jan; 207():115354. PubMed ID: 36435202
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HDL protects against doxorubicin-induced cardiotoxicity in a scavenger receptor class B type 1-, PI3K-, and Akt-dependent manner.
    Durham KK; Chathely KM; Mak KC; Momen A; Thomas CT; Zhao YY; MacDonald ME; Curtis JM; Husain M; Trigatti BL
    Am J Physiol Heart Circ Physiol; 2018 Jan; 314(1):H31-H44. PubMed ID: 28986362
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Manipulation of cardiac phosphatidylinositol 3-kinase (PI3K)/Akt signaling by apoptosis regulator through modulating IAP expression (ARIA) regulates cardiomyocyte death during doxorubicin-induced cardiomyopathy.
    Kitamura Y; Koide M; Akakabe Y; Matsuo K; Shimoda Y; Soma Y; Ogata T; Ueyama T; Matoba S; Yamada H; Ikeda K
    J Biol Chem; 2014 Jan; 289(5):2788-800. PubMed ID: 24338479
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of miR-143 regulation on cardiomyocytes apoptosis in doxorubicin cardiotoxicity based on integrated bioinformatics analysis.
    Zhou C; Yang Y; Hu L; Meng X; Guo X; Lei M; Ren Z; Chen Q; Ouyang C; Yang X
    Toxicol In Vitro; 2023 Dec; 93():105662. PubMed ID: 37597758
    [TBL] [Abstract][Full Text] [Related]  

  • 59. miR-146a attenuates apoptosis and modulates autophagy by targeting TAF9b/P53 pathway in doxorubicin-induced cardiotoxicity.
    Pan JA; Tang Y; Yu JY; Zhang H; Zhang JF; Wang CQ; Gu J
    Cell Death Dis; 2019 Sep; 10(9):668. PubMed ID: 31511497
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Carnosic acid protects against doxorubicin-induced cardiotoxicity through enhancing the Nrf2/HO-1 pathway.
    Hu S; Liu B; Yang M; Mao S; Ju H; Liu Z; Huang M; Wu G
    Food Funct; 2023 Apr; 14(8):3849-3862. PubMed ID: 37013966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.